Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 15;22(24):30550.
doi: 10.2807/1560-7917.ES.2017.22.24.30550.

Botulism in Italy, 1986 to 2015

Affiliations

Botulism in Italy, 1986 to 2015

Fabrizio Anniballi et al. Euro Surveill. .

Abstract

Botulism is a rare but severe neuroparalytic disease caused by botulinum toxins. Because of its high potential impact on public health, botulism is a closely monitored communicable disease in Europe. In Italy, which has one of the highest incidence rates in Europe (0.03 cases per 100,000 population), botulism is monitored through a case-based passive surveillance system: the front-line physician who diagnoses a suspected case must notify the Local Health Units immediately, and the Ministry of Health's office within 12 hours. From 1986 to 2015, 466 confirmed cases of botulism were recorded in Italy (of 1,257 suspected cases). Of these, 421 were food-borne (the most frequently seen form of botulism due to the consumption of improperly home-canned foods), 36 were infant botulism, which accounts for ca 50% of all these types of cases registered in Europe, six were wound-related and three were due to adult intestinal colonisation. This scenario suggests that stronger efforts should be made towards raising public awareness of the risk of food-borne botulism, especially with respect to home-preserved foods, as well as improving the training of front-line medical personnel, to ensure that a quick and accurate diagnosis of botulism can be made.

Keywords: BoNT-producing Clostridium; Botulism; Epidemiology; Infectious diseases; Surveillance.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
Suspected (n=1,254) and laboratory-confirmed cases (n=466) of botulism, Italy, 1986–2015
Figure 2
Figure 2
Annual incidence of botulism per 100,000 population, Italy, 1986–2015 (n=1,254)

References

    1. Sobel J. Botulism. Clin Infect Dis. 2005;41(8):1167-73. 10.1086/444507 - DOI - PubMed
    1. Anniballi F, Lonati D, Fiore A, Auricchio B, De Medici D, Locatelli CA. New targets in the search for preventive and therapeutic agents for botulism. Expert Rev Anti Infect Ther. 2014;12(9):1075-86. 10.1586/14787210.2014.945917 - DOI - PubMed
    1. Rossetto O, Pirazzini M, Montecucco C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol. 2014;12(8):535-49. 10.1038/nrmicro3295 - DOI - PubMed
    1. Peck MW. Biology and genomic analysis of Clostridium botulinum. Adv Microb Physiol. 2009;55:183-265, 320. 10.1016/S0065-2911(09)05503-9 - DOI - PubMed
    1. Dembek ZF, Smith LA, Rusnak JM. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities. Disaster Med Public Health Prep. 2007;1(2):122-34. 10.1097/DMP.0b013e318158c5fd - DOI - PubMed

Substances